Department of Biochemistry, B.P. Koirala Institute of Health Sciences, Dharan, Nepal.
JNMA J Nepal Med Assoc. 2020 Dec 31;58(232):1107-1111. doi: 10.31729/jnma.5705.
During this global pandemic period of COVID-19, the health care system is the most affected area. Health care workers including clinicians, laboratory professionals, and other allied health workers pose a high threat for acquiring and transmission the disease. Apart from the diagnosis of disease by the RT-PCR, other laboratory investigations are equally essential in disease prognosis and monitoring. This biosafety guidance is intended to provide and insight to the clinicians, nurses, and laboratory professionals in handling the blood and other body fluid samples for biochemical investigations concerning the proper methods of sample collection, transport, processing, and disposal. Every day, the laboratory receives samples of the patient with confirmed and suspected cases of COVID-19 patients. This poses a high threat of contamination to the health professionals and thus, a proper risk assessment and standard precautions protocol must be followed to ensure safety, minimize the risk of contamination and disease transmission.
在 COVID-19 全球大流行期间，医疗保健系统是受影响最严重的领域。医护人员包括临床医生、实验室专业人员和其他相关医疗人员，感染和传播疾病的风险很高。除了通过 RT-PCR 进行疾病诊断外，其他实验室检查对于疾病预后和监测同样至关重要。本生物安全指南旨在为临床医生、护士和实验室专业人员提供有关处理血液和其他体液样本进行生化检查的见解，包括样本采集、运输、处理和处置的正确方法。实验室每天都会收到确诊和疑似 COVID-19 患者的样本。这对卫生专业人员构成了高度的污染威胁，因此，必须遵循适当的风险评估和标准预防措施协议，以确保安全，最大程度地降低污染和疾病传播的风险。
